REGENXBIO Inc. (RGNX)

REGENXBIO Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	161.32	83.33	90.24	112.72	470.35	154.57
Revenue	161.32	83.33	90.24	112.72	470.35	154.57
Revenue Growth (YoY)	91.30%	-7.66%	-19.94%	-76.03%	204.30%	338.70%
Cost of Revenue	20.69	33.57	37.21	54.55	233.27	202.01
Gross Profit	140.63	49.76	53.03	58.18	237.08	-47.44
Selling, General & Admin	80.53	76.62	87.79	85.28	79.33	63.82
Research & Development	219.07	208.52	229.27	242.45	-	-
Other Operating Expenses	0.96	0.87	0.4	-14.18	0.33	0.3
Operating Expenses	295.56	281.01	317.46	313.56	77.1	71.79
Operating Income	-154.93	-231.25	-264.43	-255.38	159.98	-119.23
Interest Expense	-42.15	-12.66	-6.86	-23.25	-26.28	-0.77
Interest & Investment Income	19.16	18.9	11.34	5.73	7.54	13.99
EBT Excluding Unusual Items	-177.92	-225	-259.95	-272.91	141.25	-106.01
Merger & Restructuring Charges	-	-	-3.7	-	-	-
Asset Writedown	-	-2.1	-	-	-	-
Other Unusual Items	-	-	-	-7.5	-	-
Pretax Income	-177.92	-227.1	-263.65	-280.41	141.25	-106.01
Income Tax Expense	-	-	-0.15	-0.08	13.41	5.24
Net Income	-177.92	-227.1	-263.49	-280.32	127.84	-111.25
Net Income to Common	-177.92	-227.1	-263.49	-280.32	127.84	-111.25
Shares Outstanding (Basic)	51	50	44	43	42	37
Shares Outstanding (Diluted)	51	50	44	43	44	37
Shares Change (YoY)	7.47%	13.21%	1.35%	-1.73%	17.79%	1.61%
EPS (Basic)	-3.46	-4.59	-6.02	-6.50	3.01	-2.98
EPS (Diluted)	-3.46	-4.59	-6.02	-6.50	2.91	-2.98
Free Cash Flow	-	-175.56	-228.37	-238.21	134.7	-80.93
Free Cash Flow Per Share	-	-3.55	-5.22	-5.52	3.07	-2.17
Gross Margin	87.18%	59.72%	58.76%	51.61%	50.41%	-30.69%
Operating Margin	-96.04%	-277.51%	-293.02%	-226.55%	34.01%	-77.14%
Profit Margin	-110.29%	-272.54%	-291.99%	-248.68%	27.18%	-71.97%
Free Cash Flow Margin	-	-210.69%	-253.06%	-211.32%	28.64%	-52.36%
EBITDA	-139.19	-215.03	-247.11	-242.47	169.54	-110.83
EBITDA Margin	-86.28%	-258.05%	-273.83%	-215.10%	36.05%	-71.70%
D&A For EBITDA	15.74	16.22	17.32	12.91	9.56	8.41
EBIT	-154.93	-231.25	-264.43	-255.38	159.98	-119.23
EBIT Margin	-96.04%	-277.51%	-293.02%	-226.55%	34.01%	-77.14%
Effective Tax Rate	-	-	-	-	9.49%	-
Revenue as Reported	161.32	83.33	90.24	112.72	470.35	154.57

Updated Nov 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q